Transformational Epicenter
A luxury medical retreat pioneering evidence-based healing through plant medicine, bio-optimization, and trauma integration.
Healing isn't about managing symptoms.
It's about transformation.
Mental Health is Breaking
Traditional approaches are failing. Depression, anxiety, addiction, and trauma affect 1 in 5 adults, yet the system is designed for management, not healing.
0
people
suffer from depression globally
0
relapse rate
of addicts within the first year
0
annual cost
of mental health disorders
0
success rate
for traditional addiction treatment
The old paradigm isn't working
The Opportunity
A New Paradigm in Healing
Transformational Epicenter combines clinically-supervised plant medicine with cutting-edge bio-optimization and deep integration therapy. We're not treating symptoms—we're facilitating profound, lasting transformation.
Ibogaine treatment with 60-80% addiction interruption rate
Medical-grade facility with 24/7 physician oversight
Comprehensive integration for lasting behavioral change
Bio-optimization protocols enhance recovery outcomes
The Property
Riviera Maya Jungle Estate
Market Timing
Why Now?
A convergence of scientific validation, regulatory progress, and market demand creates an unprecedented opportunity.
Scientific Validation
FDA breakthrough therapy designations for psilocybin and MDMA. Johns Hopkins, NYU, and Imperial College leading research.
Regulatory Momentum
Mexico permits ibogaine treatment. Australia approved MDMA and psilocybin. US decriminalization accelerating.
Demand Explosion
Psychedelic therapy market projected to reach $10.75B by 2027. HNW individuals seeking alternatives to failed treatments.
Investment Thesis
The Investment Opportunity
$13.8M
Total Raise
All-equity seed round
$87.9M
Y5 Enterprise Value
Base case exit valuation
73.5%
Project IRR
Base case with Year 5 exit
6.69x
5-Year MOIC
Multiple on invested capital
Explore the Pitch
Dive deeper into any section of our investment thesis